136 related articles for article (PubMed ID: 32643979)
1. Pharmacokinetics, sedation and hemodynamic changes following the administration of oral transmucosal detomidine gel in cats.
Smith P; Tolbert MK; Gould E; Taylor A; Knych H; Messenger K
J Feline Med Surg; 2020 Dec; 22(12):1184-1190. PubMed ID: 32643979
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of detomidine following intravenous or oral-transmucosal administration and sedative effects of the oral-transmucosal treatment in dogs.
Messenger KM; Hopfensperger M; Knych HK; Papich MG
Am J Vet Res; 2016 Apr; 77(4):413-20. PubMed ID: 27027842
[TBL] [Abstract][Full Text] [Related]
3. Sedative effects and pharmacokinetics of detomidine when administered intravenously and intravaginally as a gel in alpacas.
Chow NS; Seddighi R; Knych HK; Sun X; Doherty TJ
Vet Anaesth Analg; 2020 Nov; 47(6):773-780. PubMed ID: 32863105
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the sedative effects and pharmacokinetics of detomidine gel administered intravaginally to horses.
Seddighi R; Knych HK; Cox SK; Sun X; Moorhead KA; Doherty TJ
Vet Anaesth Analg; 2019 Nov; 46(6):772-779. PubMed ID: 31474339
[TBL] [Abstract][Full Text] [Related]
5. Oral Transmucosal Detomidine Gel in New Zealand White Rabbits (
Williams MD; Long CT; Durrant JR; McKeon GP; Shive HR; Griffith EH; Messenger KM; Fish RE
J Am Assoc Lab Anim Sci; 2017 Jul; 56(4):436-442. PubMed ID: 28724493
[TBL] [Abstract][Full Text] [Related]
6. Sublingual administration of detomidine to calves prior to disbudding: a comparison with the intravenous route.
Hokkanen AH; Raekallio MR; Salla K; Hänninen L; Viitasaari E; Norring M; Raussi S; Rinne VM; Scheinin M; Vainio OM
Vet Anaesth Analg; 2014 Jul; 41(4):372-7. PubMed ID: 24628898
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and pharmacodynamics of detomidine following sublingual administration to horses.
Dimaio Knych HK; Stanley SD
Am J Vet Res; 2011 Oct; 72(10):1378-85. PubMed ID: 21962281
[TBL] [Abstract][Full Text] [Related]
8. Plasma concentrations, behavioural and physiological effects following intravenous and intramuscular detomidine in horses.
Mama KR; Grimsrud K; Snell T; Stanley S
Equine Vet J; 2009 Nov; 41(8):772-7. PubMed ID: 20095225
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and pharmacodynamic effects of oral transmucosal and intravenous administration of dexmedetomidine in dogs.
Dent BT; Aarnes TK; Wavreille VA; Lakritz J; Lerche P; KuKanich B; Riccó Pereira CH; Bednarski RM
Am J Vet Res; 2019 Oct; 80(10):969-975. PubMed ID: 31556717
[TBL] [Abstract][Full Text] [Related]
10. Sedative and cardiopulmonary effects of buccally administered detomidine gel and reversal with atipamezole in dogs.
Kasten JI; Messenger KM; Campbell NB
Am J Vet Res; 2018 Dec; 79(12):1253-1260. PubMed ID: 30457910
[TBL] [Abstract][Full Text] [Related]
11. The effects of yohimbine on the pharmacokinetic parameters of detomidine in the horse.
Knych HK; Steffey EP; Stanley SD
Vet Anaesth Analg; 2012 May; 39(3):221-9. PubMed ID: 22405129
[TBL] [Abstract][Full Text] [Related]
12. Sedative and cardiorespiratory effects of dexmedetomidine and buprenorphine administered to cats via oral transmucosal or intramuscular routes.
Santos LC; Ludders JW; Erb HN; Basher KL; Kirch P; Gleed RD
Vet Anaesth Analg; 2010 Sep; 37(5):417-24. PubMed ID: 20712608
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of detomidine and its metabolites following intravenous and intramuscular administration in horses.
Grimsrud KN; Mama KR; Thomasy SM; Stanley SD
Equine Vet J; 2009 Apr; 41(4):361-5. PubMed ID: 19562897
[TBL] [Abstract][Full Text] [Related]
14. Plasma drug concentrations and clinical effects of a peripheral alpha-2-adrenoceptor antagonist, MK-467, in horses sedated with detomidine.
Vainionpää MH; Raekallio MR; Pakkanen SA; Ranta-Panula V; Rinne VM; Scheinin M; Vainio OM
Vet Anaesth Analg; 2013 May; 40(3):257-64. PubMed ID: 23368795
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of sedation for standing clinical procedures in horses using detomidine combined with buprenorphine.
Taylor P; Coumbe K; Henson F; Scott D; Taylor A
Vet Anaesth Analg; 2014 Jan; 41(1):14-24. PubMed ID: 23742694
[TBL] [Abstract][Full Text] [Related]
16. Sedative and physiologic effects of orally administered alpha 2-adrenoceptor agonists and ketamine in cats.
Grove DM; Ramsay EC
J Am Vet Med Assoc; 2000 Jun; 216(12):1929-32. PubMed ID: 10863590
[TBL] [Abstract][Full Text] [Related]
17. Sedative and cardiorespiratory effects of detomidine constant rate infusion in sheep.
de Moura RS; Bittar IP; da Silva LH; Villela ACV; Dos Santos Júnior MB; Borges NC; Franco LG
Lab Anim; 2018 Feb; 52(1):51-58. PubMed ID: 28595508
[TBL] [Abstract][Full Text] [Related]
18. Effects of sedation with dexmedetomidine and buprenorphine on echocardiographic variables, blood pressure and heart rate in healthy cats.
Johard E; Tidholm A; Ljungvall I; Häggström J; Höglund K
J Feline Med Surg; 2018 Jun; 20(6):554-562. PubMed ID: 28718693
[TBL] [Abstract][Full Text] [Related]
19. Behavioural and cardiovascular effects of medetomidine constant rate infusion compared with detomidine for standing sedation in horses.
Hollis AR; Pascal M; Van Dijk J; Jolliffe C; Kaartinen J
Vet Anaesth Analg; 2020 Jan; 47(1):76-81. PubMed ID: 31619335
[TBL] [Abstract][Full Text] [Related]
20. Sedation of hyperthyroid cats with subcutaneous administration of a combination of alfaxalone and butorphanol.
Ramoo S; Bradbury LA; Anderson GA; Abraham LA
Aust Vet J; 2013 Apr; 91(4):131-6. PubMed ID: 23521097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
